Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
CDMO
667 Articles Available
1
28
Can't find what you're looking for? Try our
advanced search
.
Bispecific Antibodies
Accelerating the Development and Production of High-Quality Bispecific Antibodies
PAO-03-24-CL-01
Advanceability
Right from the Start: Designing Advanceable Formulations and Processes at Phase I
PAO-02-24-CL-09
Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System
PR-M02-05-02
CDMO - Small Biotech
Cis-Targeted Immunotherapies Need Large CDMO Expertise But Also Flexibility
Tech Transfer
Transparent Communication Supports Tech Transfers Of Cis-targeted Immunotherapies
PAO-02-24-CL-06
CDMO Rebranding
Suanfarma Unifies Its Industrial Brands in a Rebranding Initiative Under Suanfarma CDMO
PR-M01-24-03
CDMO
Advanced Technologies Unlocking the Future of Drug Manufacturing
PAO-03-24-CL-04
CDMO
Vetter becomes a member of the German Association of Research-Based Pharmaceutical Companies (vfa)
PR-M01-24-01
Chromatography
Navigating HPLC Method Development: Tips for Success
PAO-12-23-CL-09
Drug Development
Podcast: Insights from CDO Experts from Samsung Biologics
POD-01-24-CL-01
CDMO
Maximizing Outsourcing Benefits for Virtual Pharma Companies
PAO-09-23-CL-08
Process Chemistry
Enabling Client Success with Complementary Services Built upon a Strong Chemistry Foundation
PAO-12-23-CL-02
CDMO Selection
Why Fina Biosolutions Partnered With Scorpius BioManufacturing for cGMP Production of EcoCRM® (CRM197)
PAO-11-23-CL-04
Vetter joins Science Based Targets Initiative
PR-M12-23-01
Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC
PR-M11-23-01
Sustainability
Green Energy Is Almost Here: A CDMO’s Approach to Sustainability
PAO-09-23-CL-06
Strategic Partnership
Samsung Biologics and Kurma Partners Announce Strategic Partnership for Development and Manufacturing of Biologics for Kurma’s Portfolio Companies
PR-M10-23-06
Is this Pharma’s Best Kept Secret? Partnering with Australian Companies for Pharmaceutical Development and Manufacturing
In Vitro Biology
Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
PR-M10-23-04
Expansion
Vetter looks ahead to further expansions to meet supply chain demand
PR-M10-23-03
AGC Biologics Completes pDNA and mRNA Expansion at Heidelberg location
PR-M10-23-02
Wheeler Bio Announces Grand Opening of Biomanufacturing Facility
PR-M10-23-01
Formulation
Addressing Swallowing and Palatability Issues with Patient-Friendly Dosage Forms
PAO-09-23-CL-04
CDMO
Redesigning ANDA or Novel Drug Products at All Stages for the U.S. Market
PAO-08-23-CL-06
1
28
»